1417 POSTER A Phase II Trial of Afatinib (BIBW 2992) in Patients With Tumours Prospectively Screened for EGFR And/or HER2 Gene Amplification or EGFR Activating Mutations
E.L. Kwak, G.I. Shapiro, S.M. Cohen, C.R. Becerra, H.J. Lenz, S. Gooden, M. Robohn, F. Le-Maulf, V.K. Chand, A.J. lafrateVolume:
47
Year:
2011
Language:
english
DOI:
10.1016/s0959-8049(11)70910-8
File:
PDF, 43 KB
english, 2011
File converter
More search results
More benefits 
